SACS rs1057516635: What Your Genotype Means
The rs1057516635 variant is a genetic marker located within the SACS gene. It is associated with autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), a rare neurodegenerative condition characterized by progressive motor coordination issues.
What each genotype means
Typical SACS gene profile
This genotype represents the reference sequence for this location in the SACS gene. It is not associated with the clinical features of autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS).
This is the most common genotype found in the general population.
Carrier of SACS variant
This genotype indicates you carry one copy of a deletion variant in the SACS gene. Because ARSACS is an autosomal recessive condition, carrying a single copy typically does not result in the clinical symptoms of the disorder.
This heterozygous genotype is rare in the general population.
Understanding the Variant
The variant rs1057516635 is a specific change found within the SACS gene, which is located on chromosome 13. In genetic databases, this variant is tracked as a marker that may influence the structure or function of the protein encoded by this gene. Genetic variants are common throughout the human genome, and most have no impact on health. However, because this variant sits within a gene known to be critical for neurological function, researchers monitor it closely. It is important to note that the presence of a variant does not automatically imply a health condition; rather, it represents a specific sequence difference that scientists study to understand how it might contribute to biological diversity or disease risk in certain populations.
The Role of the SACS Gene
The SACS gene provides instructions for creating a protein called sacsin. This protein acts as a molecular chaperone, meaning it helps other proteins fold into their correct shapes and prevents them from clumping together, which is essential for maintaining healthy cells. Sacsin is particularly active in the brain, specifically in the cerebellum, which controls movement and balance. When the SACS gene contains certain pathogenic mutations, the resulting sacsin protein may be non-functional or absent. This disruption can lead to the accumulation of misfolded proteins, causing damage to neurons. This process is the underlying cause of autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), a condition that typically manifests as early-onset cerebellar ataxia, muscle spasticity, and peripheral neuropathy.
Research and Evidence
Scientific evidence linking SACS variants to ARSACS is considered strong, as the gene-disease relationship has been validated by multiple clinical genetics organizations. While many variants in SACS are known to cause disease, the specific clinical impact of any single variant like rs1057516635 depends on its functional effect on the sacsin protein. Research into ARSACS has expanded significantly with the use of next-generation sequencing, which has allowed scientists to identify a wide spectrum of mutations. Because ARSACS is an autosomal recessive disorder, an individual typically needs to inherit two copies of a pathogenic variant—one from each parent—to exhibit symptoms. The evidence for this specific variant is categorized as moderate, reflecting ongoing efforts to fully characterize its role in the broader phenotypic spectrum of the disease.
Population Frequency
The rs1057516635 variant is classified as rare in the general population. Because it is associated with a rare recessive disorder, it is not commonly found in large-scale genomic databases at high frequencies. The prevalence of ARSACS itself was originally identified in the Charlevoix-Saguenay region of Quebec, where it was estimated to occur in approximately 1 in 1,932 births. Outside of specific founder populations or families with a history of the condition, the likelihood of carrying this variant is very low. Genomic studies continue to refine these frequency estimates across diverse global ancestries, helping researchers understand if the variant is restricted to specific geographic regions or if it appears sporadically in other populations.
What This Information Means for You
If you have received information about this variant, it is important to interpret it within the context of your overall health and family history. Genetic testing results can be complex, and the presence of a single variant does not constitute a diagnosis of a medical condition. Because ARSACS is an autosomal recessive trait, being a carrier of one copy of a variant typically does not cause symptoms. If you are concerned about your genetic status or family history, the most appropriate step is to consult with a certified genetic counselor or a medical professional. They can help you understand the implications of your results, discuss the necessity of further diagnostic testing, and provide guidance based on your specific clinical situation. Never make medical decisions based solely on raw genetic data.
How common is this variant?
The rs1057516635 variant is considered rare across global populations, with its frequency varying significantly depending on ancestral background and regional history.
Frequently asked questions
What is ARSACS?
ARSACS stands for Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay. It is a rare, inherited neurodegenerative disorder that affects the cerebellum and peripheral nerves, leading to movement and coordination difficulties.
Is this variant a diagnosis?
No, identifying a genetic variant is not a medical diagnosis. A diagnosis for a condition like ARSACS requires a clinical evaluation by a neurologist, physical exams, and often specialized genetic testing.
What does it mean to be a carrier?
Being a carrier means you have one copy of a recessive variant. Carriers typically do not show symptoms of the condition but can pass the variant to their children.
Should I be worried if I have this variant?
Finding a variant does not necessarily mean you will develop a disease. You should discuss your results with a genetic counselor who can explain the significance of the finding in the context of your health.
Sources & further reading
Educational information only, last refreshed 10/10/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1057516635?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29